Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun;26(6):745-747.
doi: 10.5005/jp-journals-10071-24255.

First Case of Acute Myocarditis Caused by Metapneumovirus in an Immunocompromised 14-year-old Girl

Affiliations
Case Reports

First Case of Acute Myocarditis Caused by Metapneumovirus in an Immunocompromised 14-year-old Girl

Anissa Makhlouf et al. Indian J Crit Care Med. 2022 Jun.

Abstract

Background: Human metapneumovirus (hMPV) is a paramyxovirus, well known as a causative agent of respiratory tract infections. Non-respiratory manifestations, including cardiac impairments, remain rare. Only two cases of myocarditis caused by hMPV have been described in adults.

Case description: We present the case of a 14-year-old female suffering from Burkitt leukemia and diagnosed with severe myocarditis caused by hMPV, based on results from real-time polymerase chain reaction (RT-PCR) and magnetic resonance imaging (MRI). She was successfully treated by venoarterial extracorporeal membrane oxygenation and intravenous immunoglobulins. She was discharged from pediatric intensive care unit (PICU) 3 weeks later.

Conclusion: This is the first pediatric case of hMPV myocarditis requiring venoarterial extracorporeal membrane oxygenation.

How to cite this article: Makhlouf A, Peipoch L, Duport P, Darrieux E, Reguerre Y, Ramful D, et al. First Case of Acute Myocarditis Caused by Metapneumovirus in an Immunocompromised 14-year-old Girl. Indian J Crit Care Med 2022;26(6):745-747.

Keywords: Intravenous immunoglobulin; Leukemia; Metapneumovirus; Myocarditis; Venoarterial extracorporeal membrane oxygenation.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Figures

Figs 1A to D
Figs 1A to D
(A to C) High signal intensity of the myocardium in T2-weighted STIR imaging and (D) A delayed myocardial enhancement in T1-mapping suggesting myocardial inflammation

References

    1. Panda S, Mohakud NK, Pena L, Kumar S. Human metapneumovirus: review of an important respiratory pathogen. Int J Infect Dis. 2014;25:45–52. doi: 10.1016/j.ijid.2014.03.1394. - DOI - PMC - PubMed
    1. Bejiqi R, Retkoceri R, Maloku A, Mustafa A, Bejiqi H, Bejiqi R. The diagnostic and clinical approach to pediatric myocarditis: a review of the current literature. Open Access Maced J Med Sci. 2019;7(1):162–173. doi: 10.3889/oamjms.2019.010. - DOI - PMC - PubMed
    1. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7(6):719–724. doi: 10.1038/89098. - DOI - PMC - PubMed
    1. Choi MJ, Song JY, Yang TU, Jeon JH, Noh JY, Hong KW, et al. Acute myopericarditis caused by human metapneumovirus. Infect Chemother. 2016;48(1):36–40. doi: 10.3947/ic.2016.48.1.36. - DOI - PMC - PubMed
    1. Weinreich MA, Jabbar AY, Malguria N, Haley RW. New-onset myocarditis in an Iimunocompetent adult with acute metapneumovirus infection. Case Rep Med. 2015;2015:814269. doi: 10.1155/2015/814269. - DOI - PMC - PubMed

Publication types

LinkOut - more resources